Dashboard
Manage Tickers

RNA


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

novartis-projects-faster-growth-through-2030-after-raising-drug-forecasts
Novartis Projects Faster Growth Through 20...
11/20/2025 17:43:29

Novartis raises long-term sales targets, boosts outlook for key medicines and outlines a pipeline strategy driving growth throu...

heres-how-much-100-invested-in-avidity-biosciences-5-years-ago-would-be-worth-today
Here's How Much $100 Invested In Avidity B...
11/19/2025 23:00:30

looking-into-avidity-biosciences-incs-recent-short-interest
Looking Into Avidity Biosciences Inc's Rec...
11/19/2025 18:00:46

avidity-biosciences-announces-map-for-investigational-therapy-delpacibart-zotadirsen-for-eligible-people-with-duchenne-muscular-dystrophy-mutations-amenable-to-exon-44-skipping-in-us
Avidity Biosciences Announces MAP For Inve...
11/19/2025 14:15:40

Avidity Biosciences, Inc. (NASDAQ:RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics cal...

chardan-capital-maintains-neutral-on-avidity-biosciences-maintains-72-price-target
Chardan Capital Maintains Neutral on Avidi...
11/11/2025 12:59:29

Chardan Capital analyst Keay Nakae maintains Avidity Biosciences (NASDAQ:RNA) with a Neutral and maintains $72 price target.

avidity-biosciences-q3-eps-127-misses-111-estimate-sales-12475m-beat-1932m-estimate
Avidity Biosciences Q3 EPS $(1.27) Misses ...
11/10/2025 21:24:22

Avidity Biosciences (NASDAQ:RNA) reported quarterly losses of $(1.27) per share which missed the analyst consensus estimate of ...

1000-invested-in-avidity-biosciences-5-years-ago-would-be-worth-this-much-today
$1000 Invested In Avidity Biosciences 5 Ye...
10/29/2025 20:45:35

td-cowen-downgrades-avidity-biosciences-to-hold-lowers-price-target-to-74
TD Cowen Downgrades Avidity Biosciences to...
10/29/2025 13:03:20

TD Cowen analyst Ritu Baral downgrades Avidity Biosciences (NASDAQ:RNA) from Buy to Hold and lowers the price target from $7...

nucor-to-rally-more-than-14-here-are-10-top-analyst-forecasts-for-tuesday
Nucor To Rally More Than 14%? Here Are 10 ...
10/28/2025 11:48:22

this-boot-barn-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-tuesday
This Boot Barn Analyst Is No Longer Bullis...
10/28/2025 11:23:50

chardan-capital-downgrades-avidity-biosciences-to-neutral-lowers-price-target-to-72
Chardan Capital Downgrades Avidity Bioscie...
10/28/2025 11:16:10

Chardan Capital analyst Keay Nakae downgrades Avidity Biosciences (NASDAQ:RNA) from Buy to Neutral and lowers the price targ...

novartis-maintains-outlook-even-as-generics-bite-into-profits
Novartis Maintains Outlook Even As Generic...
10/28/2025 10:58:47

Novartis Q3 sales rose 8% to $13.91 billion, missing estimates, as Kisqali and Kesimpta drove growth while U.S. generics weighe...

rbc-capital-downgrades-avidity-biosciences-to-sector-perform-raises-price-target-to-72
RBC Capital Downgrades Avidity Biosciences...
10/28/2025 10:18:34

RBC Capital analyst Luca Issi downgrades Avidity Biosciences (NASDAQ:RNA) from Outperform to Sector Perform and raises the p...

merger-monday-makes-comeback-as-us-ma-tops-80-billion-in-24-hours
'Merger Monday' Makes Comeback As US M&A T...
10/28/2025 09:44:49

U.S. companies have struck more than $80 billion worth of deals in the past 24 hours, in the latest sign that mergers and acqui...

avidity-biosciences-soars-after-72-per-share-novartis-takeover
Avidity Biosciences Soars After $72 Per Sh...
10/27/2025 18:52:41

Avidity Biosciences (RNA) to be acquired by Novartis in a $12 billion cash deal. H.C. Wainwright downgrades to Neutral.

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
10/27/2025 17:05:57

citigroup-downgrades-avidity-biosciences-to-neutral-lowers-price-target-to-72
Citigroup Downgrades Avidity Biosciences t...
10/27/2025 16:43:39

Citigroup analyst Geoff Meacham downgrades Avidity Biosciences (NASDAQ:RNA) from Buy to Neutral and lowers the price target ...

raymond-james-downgrades-avidity-biosciences-to-market-perform
Raymond James Downgrades Avidity Bioscienc...
10/27/2025 15:22:24

Raymond James analyst Martin Auster downgrades Avidity Biosciences (NASDAQ:RNA) from Strong Buy to Market Perform.

janus-henderson-avidity-biosciences-bridgebio-pharma-and-other-big-stocks-moving-higher-on-monday
Janus Henderson, Avidity Biosciences, Brid...
10/27/2025 14:21:30

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
10/27/2025 12:06:22

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION